ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated
In Brief: Stoval to Receive ACCC Award; Groopman, Sigal, Named to Board of Scientific Advisors
Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista
In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling
Trending Stories
- Kevan Shokat made KRAS druggable. With daraxonrasib now in the clinic, he is “all in” on the ultimate target: p53
Shokat was named 2026 Stephenson Global Prize winner - Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Iowa’s “cancer crisis” emerges as a top issue on the campaign trail
- California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma









